132 related articles for article (PubMed ID: 22910104)
1. An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case series.
Paul J; Foss CE; Hirano SA; Cunningham TD; Pariser DM
J Am Acad Dermatol; 2013 Feb; 68(2):255-61. PubMed ID: 22910104
[TBL] [Abstract][Full Text] [Related]
2. A phase 2, open-label, investigator-initiated study to evaluate the safety and efficacy of apremilast in subjects with recalcitrant allergic contact or atopic dermatitis.
Volf EM; Au SC; Dumont N; Scheinman P; Gottlieb AB
J Drugs Dermatol; 2012 Mar; 11(3):341-6. PubMed ID: 22395585
[TBL] [Abstract][Full Text] [Related]
3. An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum.
Foss CE; Clark AR; Inabinet R; Camacho F; Jorizzo JL
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):943-9. PubMed ID: 18384543
[TBL] [Abstract][Full Text] [Related]
4. Oral apremilast in the treatment of active psoriatic arthritis: results of a multicenter, randomized, double-blind, placebo-controlled study.
Schett G; Wollenhaupt J; Papp K; Joos R; Rodrigues JF; Vessey AR; Hu C; Stevens R; de Vlam KL
Arthritis Rheum; 2012 Oct; 64(10):3156-67. PubMed ID: 22806399
[TBL] [Abstract][Full Text] [Related]
5. Alefacept for erosive lichen planus: a case series.
Chang AL; Badger J; Rehmus W; Kimball AB
J Drugs Dermatol; 2008 Apr; 7(4):379-83. PubMed ID: 18459520
[TBL] [Abstract][Full Text] [Related]
6. Complete resolution of generalized lichen planus after treatment with thalidomide.
Maender JL; Krishnan RS; Angel TA; Hsu S
J Drugs Dermatol; 2005; 4(1):86-8. PubMed ID: 15696990
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Efficacy and Safety of Apremilast in the Management of Lichen Planus.
Viswanath V; Joshi P; Dhakne M; Dhoot D; Mahadkar N; Barkate H
Clin Cosmet Investig Dermatol; 2022; 15():2593-2600. PubMed ID: 36483748
[TBL] [Abstract][Full Text] [Related]
8. Apremilast for genital erosive lichen planus in women (the AP-GELP Study): study protocol for a randomised placebo-controlled clinical trial.
Skullerud KH; Gjersvik P; Pripp AH; Qvigstad E; Helgesen ALO
Trials; 2021 Jul; 22(1):469. PubMed ID: 34284808
[TBL] [Abstract][Full Text] [Related]
9. An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.
Vender R
J Drugs Dermatol; 2011 Apr; 10(4):396-402. PubMed ID: 21455550
[TBL] [Abstract][Full Text] [Related]
10. A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata.
Mikhaylov D; Pavel A; Yao C; Kimmel G; Nia J; Hashim P; Vekaria AS; Taliercio M; Singer G; Karalekas R; Baum D; Mansouri Y; Lebwohl MG; Guttman-Yassky E
Arch Dermatol Res; 2019 Jan; 311(1):29-36. PubMed ID: 30417279
[TBL] [Abstract][Full Text] [Related]
11. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
Lonsdale-Eccles AA; Velangi S
Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
[TBL] [Abstract][Full Text] [Related]
12. Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study.
De Souza A; Strober BE; Merola JF; Oliver S; Franks AG
J Drugs Dermatol; 2012 Oct; 11(10):1224-6. PubMed ID: 23134988
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral metronidazole in treatment of cutaneous and mucosal lichen planus.
Rasi A; Behzadi AH; Davoudi S; Rafizadeh P; Honarbakhsh Y; Mehran M; Piran P; Dehghan N
J Drugs Dermatol; 2010 Oct; 9(10):1186-90. PubMed ID: 20941941
[TBL] [Abstract][Full Text] [Related]
14. Lichen striatus in adults and pimecrolimus: open, off-label clinical study.
Campanati A; Brandozzi G; Giangiacomi M; Simonetti O; Marconi B; Offidani AM
Int J Dermatol; 2008 Jul; 47(7):732-6. PubMed ID: 18613885
[TBL] [Abstract][Full Text] [Related]
15. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus.
Byrd JA; Davis MD; Rogers RS
Arch Dermatol; 2004 Jun; 140(6):715-20. PubMed ID: 15210463
[TBL] [Abstract][Full Text] [Related]
16. Oral Lichen Planus Treated With Apremilast.
Bettencourt M
J Drugs Dermatol; 2016 Aug; 15(8):1026-8. PubMed ID: 27538007
[TBL] [Abstract][Full Text] [Related]
17. Recalcitrant erosive flexural lichen planus: successful treatment with a combination of thalidomide and 0.1% tacrolimus ointment.
Eisman S; Orteu CH
Clin Exp Dermatol; 2004 May; 29(3):268-70. PubMed ID: 15115508
[TBL] [Abstract][Full Text] [Related]
18. Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: A randomized comparative study.
Malhotra AK; Khaitan BK; Sethuraman G; Sharma VK
J Am Acad Dermatol; 2008 Apr; 58(4):596-602. PubMed ID: 18158199
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of lichen planus with sulfasalazine in 20 patients.
Bauzá A; España A; Gil P; Lloret P; Vázquez Doval FJ
Int J Dermatol; 2005 Feb; 44(2):158-62. PubMed ID: 15689219
[TBL] [Abstract][Full Text] [Related]
20. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
Alexiades-Armenakas M
J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
